John Abisheganaden’s Post

View profile for John Abisheganaden, graphic

Director, Health Services Outcomes Research (NHG) & Senior Consultant (TTSH)

New research published in JAMA Network Open examined how different combinations of behavioral treatment and medication affect tobacco cessation and, going forward, how they can be used to increase the benefits of lung cancer screenings. The findings suggest that Tobacco Longitudinal Care (TLC) was most effective when implemented without modification and does not need additional pharmacist resources. Integrating the TLC program—which consists of frequent telephone coaching and over-the-counter combination nicotine replacement therapy (NRT)—with lung cancer screening was feasible and associated with clinically meaningful quit rates. In short, if we do not help people quit smoking, we will not adequately reap the benefits of lung cancer screening.

Optimizing tobacco cessation treatment with lung cancer screening

Optimizing tobacco cessation treatment with lung cancer screening

medicalxpress.com

To view or add a comment, sign in

Explore topics